Here ya go!!
The post-mastectomy pain syndrome-A systematic review of the treatment
modalities.
Caviggioli F, Klinger F, Lisa A, Rimondo A, Maione L, Vinci V, Klinger M.
Breast J. 2018 May;24(3):451-452. doi: 10.1111/tbj.12923. Epub 2017 Nov 5.
From: aptaoncology-bounce@xxxxxxxxxxxxx <aptaoncology-bounce@xxxxxxxxxxxxx> On
Behalf Of Deborah Doherty
Sent: Tuesday, December 7, 2021 9:18 AM
To: aptaoncology@xxxxxxxxxxxxx
Subject: [aptaoncology] Re: [External] Re: Qutenza for CIPN
I definitely want to read that literature if you can send it.
Thank you
Deb
On Tue, Dec 7, 2021 at 9:11 AM Cohn, Joy
<Joy.Cohn@xxxxxxxxxxxxxxxxxxxxxx<mailto:Joy.Cohn@xxxxxxxxxxxxxxxxxxxxxx>> wrote:
There is literature describing the use of topical capsaicin in Post Mastectomy
Pain Syndrome. The etiology is different, but is also a peripheral nerve pain
syndrome. I shall find the literature.
From:
aptaoncology-bounce@xxxxxxxxxxxxx<mailto:aptaoncology-bounce@xxxxxxxxxxxxx>
<aptaoncology-bounce@xxxxxxxxxxxxx<mailto:aptaoncology-bounce@xxxxxxxxxxxxx>>
On Behalf Of Deborah Doherty
Sent: Monday, December 6, 2021 7:25 PM
To: aptaoncology@xxxxxxxxxxxxx<mailto:aptaoncology@xxxxxxxxxxxxx>
Subject: [External] [aptaoncology] Re: Qutenza for CIPN
Molly
This is wonderful news! I had not heard of Qutenza. As the OTC capsaicin works
in some patients, this is a great treatment consideration for all patients.
Please keep us posted if you are provided the opportunity to use it.
Deb
On Mon, Dec 6, 2021 at 4:11 PM Reynolds Molly
<dmarc-noreply@xxxxxxxxxxxxx<mailto:dmarc-noreply@xxxxxxxxxxxxx>> wrote:
Good afternoon!
Has anyone heard anything about Qutenza (8% Capsaicin) patches for CIPN? Our
oncology APRN went to a conference where they discussed getting FDA approval
for CIPN, it is currently approved for post-shingles neuralgia and diabetic
neuropathy. Our cancer center team approached me wondering if this would be
something, once approved that I can administer? Looking at the Guide to PT
practice I feel like it would follow under some of the wound care applications.
And of course we would test balance. Your thoughts would be appreciated!
Molly Reynolds, PT, MSPT
AdventHealth Shawnee Mission Cancer Center
This message (including any attachments) is intended only for the use of the
individual or entity to which it is addressed and may contain information that
is non-public, proprietary, privileged, confidential, and exempt from
disclosure under applicable law or may constitute as attorney work product. If
you are not the intended recipient, you are hereby notified that any use,
dissemination, distribution, or copying of this communication is strictly
prohibited. If you have received this communication in error, notify us
immediately by telephone and (i) destroy this message if a facsimile or (ii)
delete this message immediately if this is an electronic communication. Thank
you.
--
Deb Doherty, PT, PhD
she/her/hers
Associate Professor
Chair of Human Movement Science Department
Chair Interprofessional Education Task Force
Coordinator of the Graduate Certificate in Oncology Rehabilitation
Oakland University
Physical Therapy Program
3176 Human Health Building Room
433 Meadowbrook Road
Rochester, Michigan 48309
Phone: (248) 364-8683; FAX: (248) 364-8660
E-mail: doherty@xxxxxxxxxxx<mailto:doherty@xxxxxxxxxxx>
--
Deb Doherty, PT, PhD
she/her/hers
Associate Professor
Chair of Human Movement Science Department
Chair Interprofessional Education Task Force
Coordinator of the Graduate Certificate in Oncology Rehabilitation
Oakland University
Physical Therapy Program
3176 Human Health Building Room
433 Meadowbrook Road
Rochester, Michigan 48309
Phone: (248) 364-8683; FAX: (248) 364-8660
E-mail: doherty@xxxxxxxxxxx<mailto:doherty@xxxxxxxxxxx>
